Bayer Aktiengesellschaft (0P6S.IL)
- Reuters
Bayer blasts 'unscientific' rejection by Mexican regulator of GMO corn permit
MEXICO CITY (Reuters) -Bayer is evaluating its legal options after Mexican health regulators for the first time rejected a GMO corn permit it was seeking, the German pharmaceutical and crop science giant said in a statement to Reuters on Friday, blasting the decision as "unscientific." Reuters reported earlier in the day that regulator Cofepris rejected the corn permit for future import as the government of President Andres Manuel Lopez Obrador hardens its opposition to genetically modified crops. "We are disappointed with the unscientific reasons that Cofepris used to deny the authorization," the statement said, identifying the rejected corn variety as using its proprietary HT3 x SmartStax Pro technology.
- Reuters
Corteva faces slow start as it takes aim at Bayer's Brazil soy reign
U.S. pesticide and seed maker Corteva Inc will take up to three times longer to break into Brazil's genetically modified soy seed market than it did in the United States, where Corteva's sales grew rapidly in recent years, the company said. Corteva is launching new genetically modified (GMO) soy seeds in top soybean grower Brazil, where rival Bayer AG has enjoyed a virtual monopoly since planting of GMOs began in the early 2000s.
- Reuters
Bayer shares up after first trial win over Roundup
Shares in Bayer AG rose 2.5% in pre-market trade on Wednesday after the German agricultural and pharmaceuticals firm won its first trial over claims its Roundup weedkiller causes cancer. A California jury found that the herbicide was not a substantial cause of a child's rare form of non-Hodgkin's lymphoma, the company said on Tuesday. Roundup-related lawsuits have dogged Bayer since it acquired the brand as part of its $63 billion purchase of agricultural seeds and pesticides maker Monsanto in 2018.
